HIM
Hillsdale Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-153,728
| Closed | -$2.82M | – | 594 |
|
|
2024
Q4 | $2.82M | Buy |
153,728
+100
| +0.1% | +$1.84K | 0.14% | 189 |
|
|
2024
Q3 | $2.36M | Buy |
153,628
+1,100
| +0.7% | +$16.9K | 0.18% | 187 |
|
|
2024
Q2 | $2.48M | Sell |
152,528
-5,160
| -3% | -$83.9K | 0.2% | 180 |
|
|
2024
Q1 | $2.92M | Buy |
157,688
+12,530
| +9% | +$232K | 0.23% | 166 |
|
|
2023
Q4 | $4.54M | Buy |
145,158
+11,340
| +8% | +$355K | 0.37% | 76 |
|
|
2023
Q3 | $2.79M | Buy |
133,818
+22,690
| +20% | +$473K | 0.26% | 148 |
|
|
2023
Q2 | $2.66M | Buy |
+111,128
| New | +$2.66M | 0.24% | 150 |
|
|
2020
Q3 | – | Sell |
-16,400
| Closed | -$795K | – | 567 |
|
|
2020
Q2 | $795K | Sell |
16,400
-1,000
| -6% | -$48.5K | 0.07% | 218 |
|
|
2020
Q1 | $735K | Sell |
17,400
-1,500
| -8% | -$63.4K | 0.09% | 194 |
|
|
2019
Q4 | $809K | Buy |
+18,900
| New | +$809K | 0.07% | 264 |
|